We are an international pharmaceutical company. Our headquarters are based in Italy, where we are deeply rooted as one of the leading companies in primary care. Thanks to our 17 subsidiaries around the world and several top distributors, we distribute our products in more than 90 countries, with a global turnover in 2019 of 1.05 billion euros. Half of this turnover is a result of our proprietary molecules, designed and developed in our R&D centers (Rifaximin, Sulodexide, Carnitine, L-methylfolate, Parnaparin). Our second market is the US. After the acquisition of Pamlab in 2016, we now have a strong hold in the nutraceuticals and medical food sectors. China, Russia and Spain are our other main markets.
billion in 2019
million in Italy
million RoW + Export & Licensing
billions in 2019
millions in Italy
millions RoW + Export & Licensing
An international pharmaceutical company founded in Italy, an organization of people led by the passion for pharmaceuticals.
Alfasigma is a leading company in Contract Manufacturing, a unique partner in outsourcing activities for the manufacturing of nearly all pharmaceutical forms.